Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 100 to 149 of 502 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 0

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
100\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
creatine kinase, ubiquitous mitochondrial precursor (ec 2.7.3.2) (u- mtck) (mia-ck) (acidic-type mitochondrial creatine kinase). [source:swissprot;acc:p12532]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9183.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11217.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22151\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
101\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj947l8.1.1 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4v7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14548.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11915.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.221\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
102\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12738.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10437.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22052\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FMO3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7495.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9130.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21815\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prefoldin subunit 3 (von hippel-lindau binding protein 1) (vhl binding protein-1) (vbp-1) (hibbj46). [source:swissprot;acc:q15765]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9545\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7868\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21314\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, short/branched chain specific, mitochondrial precursor (ec 1.3.99.-) (sbcad) (2-methyl branched chain acyl-coa dehydrogenase) (2-mebcad) (2-methylbutyryl-coenzyme a dehydrogenase) (2-methylbutyryl-coa dehydrogenase). [source:swissprot;acc:p45954]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17410.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14360\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TSFM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation factor ts, mitochondrial precursor (ef-ts) (ef-tsmt). [source:swissprot;acc:p43897]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16290.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13464.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20987\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP1A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-2 chain precursor (ec 3.6.3.9) (sodium pump 2) (na+/k+ atpase 2). [source:swissprot;acc:p50993]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11853.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9808.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20845\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PYCR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10585.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12769.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2063\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSMD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj947l8.1.6 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4w2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14466.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12031.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20239\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOP2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12584.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10470.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20189\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
111\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9940.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11929\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20002\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
112\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s26. [source:swissprot;acc:p02383]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14269.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17098\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1982\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5673.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6797.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19816\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8871.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10603.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19525\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
spir-2 protein (fragment). [source:sptrembl;acc:q8wwl2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18662.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19427\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13761.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16422.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
basic proline-rich peptide p-e (ib-9). [source:swissprot;acc:p02811]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11545\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13771.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19285\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AQP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aquaporin-cd (aqp-cd) (water channel protein for renal collecting duct) (adh water channel) (aquaporin 2) (collecting duct water channel protein) (wch-cd). [source:swissprot;acc:p41181]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14370.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
mesoderm induction early response 1. [source:refseq;acc:nm\_020948]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4302.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19216\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
presenilin-like protein 1 (ec 3.4.99.-) (sppl2b protein). [source:swissprot;acc:q8tct7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5797\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4873\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF232\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 232. [source:swissprot;acc:q9uny5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11523.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13686.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18772\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 24 (zinc finger protein 191) (zinc finger protein kox17) (retinoic acid suppression protein a) (rsg-a). [source:swissprot;acc:p17028]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13685.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF215\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 215 (bwscr2 associated zinc-finger protein 2) (baz 2). [source:swissprot;acc:q9ul58]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11522.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13684.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger imprinted 2. [source:swissprot;acc:q9nzv7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11520.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13680.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PIK3C2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22038\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18578\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18624\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9722.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11493.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18216\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDSS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9411.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11119.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
128\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11564.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9794.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18073\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14222.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12058.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17945\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
enigma protein; lim domain protein. [source:refseq;acc:nm\_005451]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14476.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17069.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MLH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna mismatch repair protein mlh1 (mutl protein homolog 1). [source:swissprot;acc:p40692]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8375.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9873.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17887\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1754\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6814\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8009\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17537\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
12314.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10489.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.17404\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f2 (ec 1.14.13.30) (cypivf2) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:p78329]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12335.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10506.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.17403\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f11 (ec 1.14.14.1) (cypivf11). [source:swissprot;acc:q9hbi6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12328.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10501\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4X1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
likely ortholog of rat cytochrome p450 4x1. [source:refseq;acc:nm\_178033]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12384.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10549.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17397\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CRYAA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha crystallin a chain. [source:swissprot;acc:p02489]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16372.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13972.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17178\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16411.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14027.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP2C2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7690.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8991.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8214.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7026.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16908\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
143\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna directed rna polymerase ii polypeptide j-related gene isoform 3; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_032959]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11124.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13005.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16904\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
144\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dna directed rna polymerase ii polypeptide j-related gene isoform 1; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_145325]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11123.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13000.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16872\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRI\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7955.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6817.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coatomer beta' subunit (beta'-coat protein) (beta'-cop) (p102). [source:swissprot;acc:p35606]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12577.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14662.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l7. [source:swissprot;acc:p18124]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11080.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9505.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16562\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTBN5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6755.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7863.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.164\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11469.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13334.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16265\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/